
Nephropathology Associates PLC Profile last edited on: 9/8/2023
CAGE: 31YN8
UEI: LFE7CWNKK1X3
Business Identifier: Highly specialized laboratory focused in arena of neuromuscular disease and kidney diagnostics. Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
10810 Executive Center Drive Suite 100
Little Rock, AR 72211
Little Rock, AR 72211
(866) 736-2529 |
support@arkanalabs.com |
www.arkanalabs.com |
Location: Single
Congr. District: 02
County: Pulask
Congr. District: 02
County: Pulask
Public Profile
With the founders having opened the doors in 2001 as Nephropathology Associates, the firm now dba Arkana Laboratories, founded by an academic renal pathologist who began reading renal biopsies. For the next 23 years he is reported as working in university settings where he read biopsies, did research, and taught. Following his desire to focus exclusively on kidney disease, he opened Nephropath and surrounded himself with physicians and staff who shared his vision to improve patient care by advancing understanding of disease and providing world-class diagnostics. Curiosity, innovations, and growing team of physicians have contributed to a constantly expanding practice such that the firm now provides renal pathology, neuropathology, ENFD testing, and biopharma services to thousands of patients across the country. In 2016, the firm was reebranded as Arkana Laboratories, a highly specialized laboratory focused in the area of neuromuscular disease and kidney diagnostics.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2024 | 2 | NIH | $1,926,567 | |
Project Title: A proprietary digital platform for precision patient identification and enrollment of clinical trials for rare kidney diseases | ||||
2023 | 2 | NIH | $2,197,042 | |
Project Title: Development of a Precision Medicine-based Diagnostic Tool for Membranous Nephropathy | ||||
2022 | 1 | NIH | $259,379 | |
Project Title: Development of specific peptide reagents for serologic monitoring of Exostosin autoantibodies in membranous lupus nephritis | ||||
2022 | 1 | NIH | $252,144 | |
Project Title: Smartphone image analysis for real time adequacy assessment during kidney biopsy | ||||
2021 | 1 | NIH | $253,103 | |
Project Title: Rapid Genotyping of ApoL1 Risk Alleles using CRISPR-Cas12a |
Key People / Management
Merri Abel
Christopher P Larsen
Shree Sharma
Patrick Walker -- Founder, Nephropathologist
Christopher P Larsen
Shree Sharma
Patrick Walker -- Founder, Nephropathologist
Company News
There are no news available.